about
Proteomic and pathway analyses reveal a network of inflammatory genes associated with differences in skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice.A high-throughput 1,536-well luminescence assay for glutathione S-transferase activity.Fine mapping reveals that promotion susceptibility locus 1 (Psl1) is a compound locus with multiple genes that modify susceptibility to skin tumor developmentA novel mechanism of skin tumor promotion involving interferon-gamma (IFNγ)/signal transducer and activator of transcription-1 (Stat1) signaling.Evidence that Gsta4 modifies susceptibility to skin tumor development in mice and humansCooperation between Stat3 and Akt signaling leads to prostate tumor development in transgenic mice.Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications.2,6-Dithiopurine, a nucleophilic scavenger, protects against mutagenesis in mouse skin treated in vivo with 2-(chloroethyl) ethyl sulfide, a mustard gas analog.Sulforaphane induces phase II detoxication enzymes in mouse skin and prevents mutagenesis induced by a mustard gas analog.Comparison of PBDE congeners as inducers of oxidative stress in zebrafish.Upregulation of the EP1 receptor for prostaglandin E2 promotes skin tumor progression.Biotransformation of methyl parathion by glutathione S-transferases.Characterization of atrazine biotransformation by human and murine glutathione S-transferases.Estradiol metabolites as isoform-specific inhibitors of human glutathione S-transferases.Differential gene expression in epidermis of mice sensitive and resistant to phorbol ester skin tumor promotion.Abstract 2730: Role of Stat1 in skin tumor promotion
P50
Q31071791-1A676416-C830-457E-B731-E72D2FD111D0Q33525153-CFEEB1B2-C548-4DF5-A4F6-4F747340428FQ33784939-6C5A446B-7749-4D6E-A7F6-4D223CFB1184Q34071264-8F4980AE-FE22-4EFD-9A01-630B302A3FAFQ34267484-29EC23F6-ECF7-4507-BA1D-9BEF90A5095AQ34633681-15EF1016-3888-412B-861F-082412851E31Q35542147-6B9908C7-2138-4C2C-9A35-1E0FC5B94E08Q36173798-E863CBF1-6E5B-472A-BBBA-ABF4633CB51EQ37244921-DAF28EBB-B2DA-4317-9EE1-2749D4BDFD91Q41461902-781D87E0-3614-4A5F-BF90-87D58B3CC6B6Q42483046-6A59BF8E-73DA-438F-BE6E-C1B3C9481F66Q44855037-98D55C5A-B41F-477F-B1B5-EDED5531C82DQ44872551-136D426B-D861-4AB6-9FE8-2AE35CFBFAD9Q45193374-51504657-A28B-489B-A04F-1BF9E79BFE62Q46619271-3CDC8DB8-5BBB-433D-870B-487E82C68E89Q60449157-91F3C073-AA25-4841-A0A7-ED53042B4D68
P50
description
American biochemist
@en
Amerikaans toxicologe
@nl
name
Erika L. Abel
@ast
Erika L. Abel
@ca
Erika L. Abel
@en
Erika L. Abel
@es
Erika L. Abel
@fr
Erika L. Abel
@nl
Erika L. Abel
@sl
type
label
Erika L. Abel
@ast
Erika L. Abel
@ca
Erika L. Abel
@en
Erika L. Abel
@es
Erika L. Abel
@fr
Erika L. Abel
@nl
Erika L. Abel
@sl
altLabel
Erika Abel
@en
prefLabel
Erika L. Abel
@ast
Erika L. Abel
@ca
Erika L. Abel
@en
Erika L. Abel
@es
Erika L. Abel
@fr
Erika L. Abel
@nl
Erika L. Abel
@sl
P1153
7202417467
P21
P31
P496
0000-0001-8791-825X